Susquehanna International Group, LLP Nrx Pharmaceuticals, Inc. Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.23 - $0.5 $3,242 - $7,049	14,099 New	14,099 $3,000
Q1 2023 May 16, 2023	BUY	$0.66 - $1.4 $34,910 - $74,053	52,895 Added 190.76%	80,623 $53,000
Q4 2022 Feb 14, 2023	SELL	$0.79 - $9.19 $12,132 - $141,130	-15,357 Reduced 35.64%	27,728 $30,000
Q3 2022 Nov 14, 2022	SELL	$0.2 - $8.07 $8,897 - $359,026	-44,489 Reduced 50.8%	43,085 $32,000
Q2 2022 Aug 15, 2022	BUY	$0.51 - $2.42 $29,052 - $137,855	56,965 Added 186.11%	87,574 $53,000
Q1 2022 May 16, 2022	SELL	$2.45 - $5.04 $118,450 - $243,668	-48,347 Reduced 61.23%	30,609 $75,000
Q4 2021 Feb 14, 2022	BUY	$4.5 - $11.91 $106,326 - $281,409	23,628 Added 42.71%	78,956 $377,000
Q3 2021 Nov 15, 2021	BUY	$8.52 - $24.77 $471,394 - $1.37 Million	55,328 New	55,328 $513,000

17.4K

Ticker NRXP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,641,296
Market Cap $102M
Description
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-10...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.